Interestingly, HCC cells simultaneously harboring wild-type TP53 and higher CTNNB1 expression were the most resistant to paclitaxel (Figure 5B), confirming that higher mitotic gene signature expression contributes to the increased sensitivity to paclitaxel. Here, TP53 is linked to hepatocellular carcinoma.